Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage

Mrochen A, Sprügel M, Gerner S, Sembill J, Lang S, Lücking H, Kuramatsu J, Huttner H (2020)

Publication Type: Journal article

Publication year: 2020

Journal

Cerebrovascular Diseases Karger Publishers

Abstract

Background: Prevention of hematoma enlargement in oral anticoagulation-associated intracerebral hemorrhage (OAC-ICH) focuses on blood pressure (BP) reduction and OAC reversal. We investigated whether treatment efficiency and clinical outcomes differ between OAC-ICH patients admitted outside versus during regular working hours. Methods: Based on pooled data of multicenter cohort studies, we grouped OAC-ICH patients (vitamin K antagonist [VKA], non-vitamin K oral anticoagulant [NOAC]) according to on-vs. off-hour admission. Primary outcome was the functional outcome using the modified Rankin scale (mRS) dichotomized into favorable (mRS 0-3) and unfavorable (mRS 4-6) and mortality at 3 months. Secondary outcome measures included the occurrence of hematoma enlargement, the proportions of patients with systolic BP <140 mm Hg and with anticoagulation treatment achieving international normalized ratio (INR) levels <1.3 at 4 h. Propensity score matching (PSM) was performed to account for imbalances in baseline characteristics. Results: The study population consisted of 76/126 NOAC-ICH patients and 1,005/1,470 VKA patients presenting during off-hours. Functional outcome and mortality rates were not significantly different among PSM patients with VKA-ICH and NOAC-ICH during on-vs. off-hours (mRS 4-6 VKA-ICH: On-hour: 239/357 [66.9%] vs. 253/363 [69.7%] off-hour; p = 0.43; NOAC-ICH: On-hour 26/42 [61.9%] vs. off-hour: 37/57 [64.9%]; p = 0.76; mRS 6 VKA-ICH: On-hour: 127/357 [35.6%] vs. off-hour: 148/363 [40.8%]; p = 0.15;-NOAC-ICH: On-hour 17/42 [40.5%] vs. off-hour: 16/57 [28.1%]; p = 0.20). There were no differences detectable regarding the secondary outcome measures (i.e., hematoma enlargement, the proportion of patients who achieved systolic BP levels <140 mm Hg at 4 h as well as anticoagulation treatment achieving INR levels <1.3 at 4 h) in OAC patients. Conclusion: Our study implies that BP reduction and anticoagulation reversal management are well established and associated with similar rates of hematoma enlargement and clinical outcomes in on-vs. off-hour admitted OAC-ICH patients.

Authors with CRIS profile

Anne Mrochen Department of Neurology Maximilian Sprügel Department of Neurology Stefan Gerner Department of Neurology Jochen Sembill Department of Neurology Hannes Lücking Department of Neuroradiology Joji Kuramatsu Lehrstuhl für Neurologie Hagen Huttner Medizinische Fakultät

How to cite

APA:

Mrochen, A., Sprügel, M., Gerner, S., Sembill, J., Lang, S., Lücking, H.,... Huttner, H. (2020). Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage. Cerebrovascular Diseases. https://doi.org/10.1159/000507316

MLA:

Mrochen, Anne, et al. "Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage." Cerebrovascular Diseases (2020).

BibTeX: Download